Sunday, September 14, 2014 5:44:19 PM
September 13th, 2014 -- by Hanz Christensen
Click For watchlistnews.com Link
Synchrony Financial (NYSE:SYF) has earned a consensus recommendation of “Buy” from the twelve ratings firms that are covering the company, StockRatingsNetwork reports. Four analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. The average 1-year price target among brokers that have issued a report on the stock in the last year is $28.91.
Synchrony Financial (NYSE:SYF) traded down 0.61% on Tuesday, hitting $24.50. 1,106,815 shares of the company’s stock traded hands. Synchrony Financial has a 1-year low of $22.60 and a 1-year high of $26.02. The stock’s 50-day moving average is $24.30 and its 200-day moving average is $24.30. The company has a market cap of $20.427 billion and a price-to-earnings ratio of 10.44.
A number of analysts have recently weighed in on SYF shares. Analysts at BMO Capital Markets initiated coverage on shares of Synchrony Financial in a research note on Tuesday. They set a “market perform” rating on the stock. Separately, analysts at Bank of America initiated coverage on shares of Synchrony Financial in a research note on Tuesday. They set a “buy” rating and a $30.00 price target on the stock. Finally, analysts at Citigroup Inc. initiated coverage on shares of Synchrony Financial in a research note on Tuesday. They set a “buy” rating and a $30.00 price target on the stock.
Synchrony Financial (NYSE:SYF) is a consumer financial services companies in the United States.
TRUTH
I've never claimed to have all the answers but feel i'm beginning to corner the market in questions worthy of solutions.
Recent SYF News
- Synchrony Extends Partnership with Affordable Care Offering CareCredit to Patients • PR Newswire (US) • 05/02/2024 01:00:00 PM
- Synchrony and ServiceTitan Join Forces to Streamline Home Improvement Financing • PR Newswire (US) • 04/30/2024 01:00:00 PM
- Synchrony Reports First Quarter 2024 Results; Company also Announces Quarterly Stock Dividends and Approval of an Incremental $1.0 Billion Share Repurchase Program • PR Newswire (US) • 04/24/2024 10:13:00 AM
- Synchrony Expands Dental Payment Offerings with Adit Practice Management Software Partnership • PR Newswire (US) • 04/18/2024 01:00:00 PM
- Synchrony Partners with BRP to Provide Retail Financing Options in the United States • PR Newswire (US) • 04/08/2024 01:00:00 PM
- SYNCHRONY RECOGNIZED FOR ITS PEOPLE-CENTRIC CULTURE WITH NEW COMPANY RANKING • PR Newswire (US) • 04/04/2024 12:38:00 PM
- Synchrony to Announce First Quarter 2024 Financial Results on April 24, 2024 • PR Newswire (US) • 03/26/2024 12:00:00 PM
- Skipify and Synchrony Enter into Strategic Partnership to Simplify and Enhance Online Checkout • PR Newswire (US) • 03/13/2024 01:00:00 PM
- IPH ENTERS STRATEGIC PARTNERSHIP WITH SYNCHRONY AND COMPLETES ACQUISITION OF PETS BEST • PR Newswire (US) • 03/06/2024 04:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 12:30:26 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 12:30:09 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 12:29:56 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 12:29:35 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 12:29:20 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 12:29:07 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 12:28:56 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 12:28:41 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/05/2024 10:24:06 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/05/2024 09:40:35 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/05/2024 09:00:31 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/05/2024 08:45:25 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/05/2024 06:52:54 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/05/2024 05:41:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2024 01:30:44 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/04/2024 04:42:46 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM